Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF

Multiple molecular subtypes and distinct clinical outcomes in breast cancer, necessitate specific therapy. Moreover, despite the improvements in breast cancer therapy, it remains the fifth cause of cancer-related deaths, indicating the involvement of unknown genes. To identify novel contributors and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Bratati, Tiwari, Ankit, Palo, Ananya, Pattnaik, Niharika, Samantara, Subrat, Dixit, Manjusha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633810/
https://www.ncbi.nlm.nih.gov/pubmed/36329016
http://dx.doi.org/10.1038/s41420-022-01240-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633810/
https://www.ncbi.nlm.nih.gov/pubmed/36329016
http://dx.doi.org/10.1038/s41420-022-01240-w

Ejemplares similares